More about Jyothy Labs Limited
Fundamentals for Jyothy Labs Limited
Regulatory Filings for Jyothy Labs Limited
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
Fundamentals for Jyothy Labs Limited
Business Operations:
Sector: Consumer DefensiveIndustry: Household & Personal Products
Jyothy Labs Limited, together with its subsidiaries, engages in the manufacture and marketing of fabric care, dishwashing, personal care, and household insecticides products in India and internationally. It operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, and Others segments. The Dishwashing segment offers dish wash bars, gels, and liquids, as well as dish wash scrubbers and powders under the Pril and Exo brands. The Fabric Care segment provides fabric whiteners, fabric enhancers, detergent powders, and detergent liquids and bar soaps under the Henko, Mr. White, Ujala, and More light brands. The Household Insecticides segment offers mosquito repellent coils, liquids, and insect repellent sticks, as well as surface cleaners and air care products under the Maya, T- Shine, and Maxo brands. The Personal Care segment provides body soaps, toothpastes, deodorants, talcum powders, after shave products, and hand washes under the Margo, Fa, and Neem Active brands. The Others segment offers incense sticks under the Maya brand; toilet and floor cleaner products; and provides dry cleaning and laundry services under the Fabric Spa brand. The company was formerly known as Jyothy Laboratories Limited and changed its name to Jyothy Labs Limited in July 2019. Jyothy Labs Limited was founded in 1983 and is based in Mumbai, India.
Revenue projections:
JYOTHYLAB's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.
Financial Ratios:
| currentRatio | 2.683000 |
|---|---|
| forwardPE | 18.464863 |
| debtToEquity | 3.247000 |
| earningsGrowth | -0.116000 |
| revenueGrowth | 0.042000 |
| grossMargins | 0.469530 |
| operatingMargins | 0.112820 |
| trailingEps | 9.300000 |
| forwardEps | 11.099460 |
JYOTHYLAB's current ratio of 2.683 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as JYOTHYLAB can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
Jyothy Labs Limited's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
Jyothy Labs Limited's low growth in both earnings and revenue indicates potential profit shrinkage. This downward trend could be a sign of weakening financial health, signaling challenges for the company's future profitability.
Jyothy Labs Limited's negative gross and operating margins point to losses in both production and operations. This suggests the company is facing financial challenges and may need to address cost management or improve revenue generation.
Jyothy Labs Limited's forward EPS exceeding its trailing EPS reflects expectations of increased profitability for the current year. This suggests that the company is projected to achieve higher earnings than in the previous financial year, signaling positive growth and improved financial health.
Price projections:
The current price of JYOTHYLAB aligns with projections, showing no clear risks or opportunities. This lack of volatility suggests a stable environment for investors, who may wish to hold off on major adjustments until market conditions change.
Recommendation changes over time:
Analysts' buy bias toward JYOTHYLAB suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, JYOTHYLAB is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
How Independent Directors Failed Rs 2,500 Crore in Value
India’s Stock Market May Be Sitting on a Trap